Clinical Trials Browser

Completed × Neoplasm Metastasis × Ado-Trastuzumab Emtansine × Clear all

NCT01835236 2021-03-30

Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis